PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Contraceptive use among women with multiple sclerosis: a systematic review.

Abstract Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).
PMID
Related Publications

Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review.

Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.

Contraceptive safety among women with cystic fibrosis: a systematic review.

Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.

Authors

Mayor MeshTerms
Keywords

Combined oral contraceptives

Contraception

Multiple sclerosis

Oral contraceptives

Systematic review

Journal Title contraception
Publication Year Start
%A Zapata, Lauren B.; Oduyebo, Titilope; Whiteman, Maura K.; Houtchens, Maria K.; Marchbanks, Polly A.; Curtis, Kathryn M.
%T Contraceptive use among women with multiple sclerosis: a systematic review.
%J Contraception
%D 07/2016
%M ENG
%B Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).
%Y 10.1016/j.contraception.2016.07.013
%W PHY
%G AUTHOR
%R 2016..............Z

@Article{Zapata2016,
author="Zapata, Lauren B.
and Oduyebo, Titilope
and Whiteman, Maura K.
and Houtchens, Maria K.
and Marchbanks, Polly A.
and Curtis, Kathryn M.",
title="Contraceptive use among women with multiple sclerosis: a systematic review.",
journal="Contraception",
year="2016",
month="Jul",
day="21",
abstract="Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).",
issn="1879-0518",
doi="10.1016/j.contraception.2016.07.013",
url="http://www.ncbi.nlm.nih.gov/pubmed/27452316",
language="ENG"
}

%0 Journal Article
%T Contraceptive use among women with multiple sclerosis: a systematic review.
%A Zapata, Lauren B.
%A Oduyebo, Titilope
%A Whiteman, Maura K.
%A Houtchens, Maria K.
%A Marchbanks, Polly A.
%A Curtis, Kathryn M.
%J Contraception
%D 2016
%8 Jul 21
%@ 1879-0518
%G ENG
%F Zapata2016
%X Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).
%U http://dx.doi.org/10.1016/j.contraception.2016.07.013
%U http://www.ncbi.nlm.nih.gov/pubmed/27452316

PT Journal
AU Zapata, LB
   Oduyebo, T
   Whiteman, MK
   Houtchens, MK
   Marchbanks, PA
   Curtis, KM
TI Contraceptive use among women with multiple sclerosis: a systematic review.
SO Contraception
PD Jul
PY 2016
DI 10.1016/j.contraception.2016.07.013
LA ENG
AB Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).
ER

PMID- 27452316
OWN - NLM
STAT- Publisher
DA  - 20160805
LR  - 20160805
IS  - 1879-0518 (Electronic)
IS  - 0010-7824 (Linking)
DP  - 2016 Jul 21
TI  - Contraceptive use among women with multiple sclerosis: a systematic review.
LID - S0010-7824(16)30167-6 [pii]
LID - 10.1016/j.contraception.2016.07.013 [doi]
AB  - BACKGROUND: Contraception is an important consideration for women with multiple
      sclerosis (MS); however, little is known about the possible effects of hormonal
      contraception on disease progression or other adverse outcomes (e.g., thrombosis,
      low bone mineral density). OBJECTIVE: To evaluate the evidence on the safety of
      contraceptive use among women with MS. SEARCH STRATEGY: We searched the PubMed
      database for peer-reviewed articles published in any language from database
      inception through July 2015. SELECTION CRITERIA: We included studies that
      examined health outcomes among women diagnosed with MS initiating or continuing a
      contraceptive method. We excluded case reports and case series but included all
      other study designs. RESULTS: From 111 articles, we identified four studies (from
      5 articles) that met our inclusion criteria. Evidence from one randomized
      controlled trial, two retrospective cohort studies, and one cross-sectional study
      suggests that use of combined oral contraceptives (COCs) or oral contraceptives
      (OCs) (type not specified) among women with MS does not worsen the clinical
      course of disease, defined as disability level, disease severity or progression, 
      relapse or number of new brain lesions on magnetic resonance imaging (body of
      evidence grading Level I, fair to Level II-3, poor). No studies were identified
      that examined the safety of other contraceptive methods or examined other
      outcomes of interest (venous thromboembolism, changes in bone mineral density)
      related to contraceptive use among women with MS. CONCLUSIONS: Limited evidence
      suggests that COC or OC use after MS onset does not worsen the clinical course of
      disease.
CI  - Published by Elsevier Inc.
FAU - Zapata, Lauren B
AU  - Zapata LB
AD  - Division of Reproductive Health, US Centers for Disease Control and Prevention,
      Chamblee, Georgia, 30341-3717. Electronic address: [email protected]
FAU - Oduyebo, Titilope
AU  - Oduyebo T
AD  - Division of Reproductive Health, US Centers for Disease Control and Prevention,
      Chamblee, Georgia, 30341-3717.
FAU - Whiteman, Maura K
AU  - Whiteman MK
AD  - Division of Reproductive Health, US Centers for Disease Control and Prevention,
      Chamblee, Georgia, 30341-3717.
FAU - Houtchens, Maria K
AU  - Houtchens MK
AD  - Department of Neurology, Partners Multiple Sclerosis Center, Brigham and Women's 
      Hospital, Harvard Medical School, Boston, MA 02115.
FAU - Marchbanks, Polly A
AU  - Marchbanks PA
AD  - Division of Reproductive Health, US Centers for Disease Control and Prevention,
      Chamblee, Georgia, 30341-3717.
FAU - Curtis, Kathryn M
AU  - Curtis KM
AD  - Division of Reproductive Health, US Centers for Disease Control and Prevention,
      Chamblee, Georgia, 30341-3717.
LA  - ENG
PT  - REVIEW
PT  - JOURNAL ARTICLE
DEP - 20160721
TA  - Contraception
JT  - Contraception
JID - 0234361
OTO - NOTNLM
OT  - Combined oral contraceptives
OT  - Contraception
OT  - Multiple sclerosis
OT  - Oral contraceptives
OT  - Systematic review
EDAT- 2016/07/28 06:00
MHDA- 2016/07/28 06:00
CRDT- 2016/07/26 06:00
PHST- 2016/02/16 [received]
PHST- 2016/07/13 [revised]
PHST- 2016/07/18 [accepted]
AID - S0010-7824(16)30167-6 [pii]
AID - 10.1016/j.contraception.2016.07.013 [doi]
PST - aheadofprint
SO  - Contraception. 2016 Jul 21. pii: S0010-7824(16)30167-6. doi:
      10.1016/j.contraception.2016.07.013.
TY  - JOUR
AU  - Zapata, Lauren B.
AU  - Oduyebo, Titilope
AU  - Whiteman, Maura K.
AU  - Houtchens, Maria K.
AU  - Marchbanks, Polly A.
AU  - Curtis, Kathryn M.
PY  - 2016/Jul/21
TI  - Contraceptive use among women with multiple sclerosis: a systematic review.
JO  - Contraception
N2  - Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).
SN  - 1879-0518
UR  - http://dx.doi.org/10.1016/j.contraception.2016.07.013
UR  - http://www.ncbi.nlm.nih.gov/pubmed/27452316
ID  - Zapata2016
ER  - 
<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
<b:Source>
<b:Tag>Zapata2016</b:Tag>
<b:SourceType>ArticleInAPeriodical</b:SourceType>
<b:Year>2016</b:Year>
<b:Month>Jul</b:Month>
<b:Day>21</b:Day>
<b:PeriodicalName>Contraception</b:PeriodicalName>
<b:Author>
<b:Author><b:NameList>
<b:Person><b:Last>Zapata</b:Last><b:First>Lauren</b:First><b:Middle>B</b:Middle></b:Person>
<b:Person><b:Last>Oduyebo</b:Last><b:First>Titilope</b:First></b:Person>
<b:Person><b:Last>Whiteman</b:Last><b:First>Maura</b:First><b:Middle>K</b:Middle></b:Person>
<b:Person><b:Last>Houtchens</b:Last><b:First>Maria</b:First><b:Middle>K</b:Middle></b:Person>
<b:Person><b:Last>Marchbanks</b:Last><b:First>Polly</b:First><b:Middle>A</b:Middle></b:Person>
<b:Person><b:Last>Curtis</b:Last><b:First>Kathryn</b:First><b:Middle>M</b:Middle></b:Person>
</b:NameList></b:Author>
</b:Author>
<b:Title>Contraceptive use among women with multiple sclerosis: a systematic review.</b:Title>
<b:Comments>Contraception is an important consideration for women with multiple sclerosis (MS); however, little is known about the possible effects of hormonal contraception on disease progression or other adverse outcomes (e.g., thrombosis, low bone mineral density).</b:Comments>
</b:Source>
</b:Sources>